Document:

<PAGE>
                                                                   Exhibit 10.18

                            ACCOUNT CONTROL AGREEMENT
                                (THE "AGREEMENT")

This Account Control Agreement ("Agreement") is made and entered as of this 6th
day of July, 2005 by and among HERCULES TECHNOLOGY GROWTH CAPITAL, INC., a
Maryland corporation ("Lender"), with its principal place of business located at
525 University Avenue, Suite 700, Palo Alto, CA 94301 (the "CREDITOR"), OMRIX
BIOPHARMACEUTICALS, INC., a Delaware corporation, with its chief executive
office and principal place of business located at Chauss'ee de Waterloo, 200
B-1640 Rhode St. Genese Belgium (the "CUSTOMER"), and HSBC Bank USA, National
Association, 452 Fifth Avenue, New York, N.Y. 10018 (the "BANK").

BACKGROUND

Pursuant to the Loan and Security Agreement between Creditor and Customer dated
March 31, 2005 ("Loan Agreement"), the Customer has granted the Creditor a
security interest, among other things, in the Account (as defined below)
maintained by Customer at the Bank and in all funds currently or hereafter
deposited into such Account, including any interest accrued thereon. The parties
are entering into this Agreement to perfect the Creditor's security interest in
such Account. Bank is not a party to the Loan Agreement or any other agreement
between Creditor and Customer and all of Bank's rights, duties and obligations
are stated in this Account Control Agreement without reference to any other
agreement.

1. The Account. The Customer represents and warrants to the Creditor that the
Customer has established the following account at the Bank:

Account number: 605139458 (the "ACCOUNT").

As of the date hereof, the Bank is not aware of any claim to, or interest in,
the Account, except for claims and interests of the parties referred to in this
Agreement. The Customer agrees that if Customer opens any additional accounts at
the Bank, this Agreement will be deemed to have been amended to include the new
account as an Account, but only if Customer uses the same private client group
to open such additional accounts that was used to open the Account and notifies
that private client group at the time each additional account is opened that it
is subject to this Agreement. The Customer agrees that if it opens additional
accounts with the Bank, it shall be with the same private client group that was
used to open the Account.

2. Control of Accounts by Creditor

     a. The Customer and the Creditor agree that upon the occurrence of an Event
of Default (as such term is defined in the Loan Agreement), the Creditor may
deliver written instructions (the "DEFAULT ORDER") in the form attached hereto
as Exhibit A to the Bank and the Bank will, as soon as reasonably possible upon
receipt, comply with such Default Order delivered by the Creditor, without
requiring any further consent from the Customer and without regard to any
inconsistent or conflicting orders provided to the Bank by the Customer or
anyone on its behalf. Bank shall promptly confirm receipt of the Default Order
to Creditor; until Creditor receives Bank's written confirmation that the
Default Order has been received, it shall be presumed that the Default Order

<PAGE>

was not received. For purposes hereof, "BUSINESS DAY" shall mean any day of the
year on which New York State chartered banks are required by law to be open to
the public for conducting business.

     b. It is hereby clarified that for so long as the Bank has not received a
Default Order from the Creditor, the Customer shall be fully entitled and
authorized to withdraw and deposit any and all funds available in the Accounts.

     c. Without limiting and in addition to the requirements set forth in
paragraph (a) of this Section 2, the Creditor agrees that before it attempts to
deliver a Default Order relating to the Account to the Bank, the Creditor shall
deliver to the Bank, such documentation as the Bank may, from time to time,
reasonably request, certifying the person or persons authorized by Creditor to
sign a Default Order. In absence of such documentation the Bank may rely and
shall be protected in acting or refraining from acting upon any Default Order
believed by the Bank to be genuine and to have been signed by the proper party,

3. Priority of Creditor's Security Interest: Rights Reserved by the Bank

     a. The Bank agrees that all of its present and future rights with respect
to the Account axe subordinated to the Creditor's security interest therein;
provided, however, that the Creditor agrees that the Bank expressly reserves all
of its present and future rights (whether described as rights of setoff, bankers
lien, chargeback or otherwise, and whether available to Bank under law or under
any written agreement), including, but not limited to, the right to withdraw
from the Account an amount (i) to cover the reversal of a provisional credit,
(ii) to recover funds improperly or incorrectly credited to the Account, and
(iii) to pay any Account fees or fees associated with the aforementioned. If any
checks, drafts or other items deposited or funds wired or otherwise transferred
or deposited into the Account are returned unpaid or otherwise dishonored or are
returned because of improper or incorrect crediting, then the Bank shall have
the right, whether or not a Default Order has been received, to charge the
Account for the amount of such deposit or transfer and any fees or charges
associated with such return, dishonor or requirement.

     b. Upon the termination of this Agreement, Creditor shall have no further
right to deliver to the Bank Default Orders relating to the Account or otherwise
control the Account, and the Bank shall take such steps as the Customer may
reasonably request to vest full ownership and control of the Accounts with
Customer.

4. Governing Law. This Agreement and the Account will be governed by the laws of
the State of New York. The Bank may not change the law governing the Account
without the Creditor's express written consent, which consent shall not be
unreasonably withheld.

5. Entire Agreement. This Agreement and all exhibits attached hereto constitute
the full and entire understanding and agreement between the parties with regard
to the subject matters hereof and supersede any prior agreement or arrangement
(whether written or oral).

6. Amendments. No amendment of, or waiver of a right under, this Agreement will
be binding unless it is in writing and signed by all parties hereto.

7. Severability. If any provision of this Agreement is held by a court of
competent jurisdiction to be unenforceable under applicable law, then such
provision shall be excluded from this Agreement and

<PAGE>

the remainder of this Agreement shall be interpreted as if such provision were
so excluded and shall be enforceable in accordance with its terms; provided,
however, that in such event this Agreement shall be interpreted so as to give
effect, to the greatest extent consistent with and permitted by applicable law,
to the meaning and intention of the excluded provision as determined by such
court of competent jurisdiction

8. Other Agreements. For so long as this Agreement remains in effect,
transactions involving the Accounts shall be subject, except to the extent
inconsistent herewith, to the provisions of the Bank's account agreements,
disclosures, and fee schedules as are in effect from time to time for accounts
similar to the Account.

9. Successors and Assigns. The provisions of this Agreement shall be binding
upon and inure to the benefit of the Bank, Creditor and Customer and their
respective successors and assigns.

10. Notices, A notice or other communication to a party under this Agreement
will be in writing and will be sent to the party's address set forth below or to
such other address as the party may notify the other parties, and will be
effective on receipt.

If to the Customer:   To: OMRIX BIOPHARMACEUTICALS, INC.
                      Address: Chauss'ee de Waterloo, 200 B-1640
                               Rhode St. Genese Belgium
                      Attention: Michael Burshtine
                      Facsimile: +32-2-3599149

If to Creditor:       To:
                      HERCULES TECHNOLOGY GROWTH CAPITAL, INC.
                      Legal Department
                      Attention: Chief Legal Officer
                      525 University Avenue
                      Suite 700
                      Palo Alto, CA 94301
                      Facsimile: 650-473-9194

                      With a copy to:
                      HERCULES TECHNOLOGY GROWTH CAPITAL, INC.
                      Attention: Parag Shah
                      2 Oliver Street
                      Suite 611
                      Boston, MA 02110
                      Facsimile: 617 261 6551

If to the Bank:       To: HSBC Bank USA, National Association
                      452 Fifth Avenue
                      New York, NY 10018
                      Attention: Isaac Douek, Senior Vice President
                      6th Floor
                      Facsimile: 212-525-5882

<PAGE>

                      With a copy to:
                      HSBC Bank USA, National Association
                      IPB NY CREDIT ADMINISTRATION
                      1 West 39th Street
                      New York, NY 10018
                      Attention: Maria Fucci, First Vice President/Manager
                      7th Floor
                      Facsimile: 212-525-0122

11. Counterparts. This Agreement may be executed in counterparts, each of which
shall be an original and all of which shall constitute but one and the same
instrument.

12. Heading, Preamble, and Exhibits. The titles and subtitles used in this
Agreement are used for convenience only and are not to be considered in
construing or interpreting this Agreement. The Preamble and Exhibits are an
integral and inseparable part of this Agreement.

13. Further Action. At any time and from time to time, the Customer and the
Creditor each agrees, without further consideration, to take such actions and to
execute and deliver such documents as, in the Bank's opinion, may be reasonably
necessary to carry out and give full effect to the provisions of this Agreement
and the intentions of the parties as reflected hereby and thereby.

14. Expenses. Each party will pay its expenses, if any, relating to the
execution of this Agreement and the transactions contemplated herein.

15. Delays or Omissions. No delay or omission to exercise any right, power, or
remedy accruing to the Creditor pursuant to the provisions of this Agreement,
shall be deemed a waiver by the Creditor of such right.

16. Limited Responsibility of Bank. The Bank shall have no responsibility or
liability to Creditor for complying with instructions concerning the Account
from Customer or Customer's authorized representatives that are received by the
Bank before the Bank has received a Default Order and has had a reasonable
opportunity to act upon such Default Order. The Bank shall have no
responsibility or liability to Customer for complying with a Default Order and
shall have no responsibility to investigate the genuineness, accuracy, validity
or appropriateness of any instructions or Default Order or any signature on such
instructions or Default Order, even if the Customer notifies the Bank that
Creditor is not legally entitled to originate such Default Order. The Bank may
act in reliance upon any signature believed by it to be genuine and may assume
that any person who has been designated by Customer or Creditor to give
instructions or a Default Order pursuant to this Agreement or the Account has
been duly authorized to do so.

17. Exculpation of Bank: Indemnification by Customer. Customer and Creditor
agree that the Bank shall have no liability to either of them for any loss or
damage that either or both may claim to have suffered or incurred, either
directly or indirectly, by reason of this Agreement or any transaction or
service contemplated by the provisions hereof, unless such loss or damage result
from the gross negligence or willful misconduct of the Bank. In no event shall
Bank be liable for losses or delays resulting from computer malfunction,
interruption of communication facilities, labor difficulties or other causes
beyond the Bank's reasonable control or for indirect, special, punitive or
consequential, damages. Customer agrees to indemnify the Bank and hold it
harmless from and

<PAGE>

against any and all claims made against the Bank by Creditor or any other person
or entity, other than those ultimately determined to be founded on the gross
negligence or willful misconduct of the Bank, and from and against any damages,
penalties, judgments, liabilities, losses or expenses (including reasonable
attorney's fees and disbursements) incurred as a result of the assertion of any
such claim made against the Bank by Creditor or any person or entity arising out
of, or otherwise related to, any compliance by the Bank with a Default Order or
this Agreement. Creditor agrees that it shall not assert any claim against the
Bank other than with respect to an alleged non-compliance by the Bank with any
Default Order.

IN WITNESS WHEREOF the parties have signed this Agreement in one or more
counterparts as of the date first appearing above.

<PAGE>

OMRIX BIOPHARMACEUTICALS, INC.

By: /s/ Michael Burshtine
    ---------------------------------
Name: Michael Burshtine
Title: CFO

HERCULES TECHNOLOGY GROWTH CAPITAL, INC.

By: /s/ Scott Harvey
    ---------------------------------
Name: Scott Harvey
Title: Chief Legal Officer

HSBC BANK USA, NATIONAL ASSOCIATION

By  /s/ Isaac Douek
    ---------------------------------
Name: Isaac Douek
Title: Senior Vice President

<PAGE>

                                    EXHIBIT A

HSBC Bank USA, National Association
452 Fifth Avenue,
New York, NY 10018
Attention: Isaac Douek, Senior Vice President, 6th Floor
Copy to: Attention: Maria Fucci. First Vice President/Manager
IPB NY CREDIT ADMINISTRATION 7th Floor, 1 West 39th St.
New York, NY 10018

Date: __________________

Re: NAME OF CUSTOMER.- Default Order

Dear Sir,

Please be informed that an Event of Default (as such term is defined in that
certain Loan and Security Agreement (the "LOAN AGREEMENT") between Omrix
Biopharmaceuticals, Inc. ("Customer") and Hercules Technology Growth Capital,
Inc. ("Creditor"); dated March 31, 2005), has occurred and was not cured
according to the Loan Agreement. In accordance with the Account Control
Agreement ("Agreement") between Customer. Creditor and HSBC Bank USA, National
Association (the "Bank") dated July 6, 2005, you are hereby given a Default
Order (as such term is defined in the Agreement) to promptly cease to comply
with any orders or instructions originated by the Customer concerning the
Account (as defined in the Agreement).

Furthermore, you are hereby instructed to comply with the following instructions
with respect to such Account:

___________ Cease any transfer or withdrawal of funds from the Account

___________ Effect the transfer of US$[_____] to the Creditor, out of the funds
available in such Account.

Sincerely,

HERCULES TECHNOLOGY GROWTH CAPITAL, INC.

By:
    ---------------------------------

By:
    ---------------------------------
Name:
      -------------------------------
Title:
       ------------------------------<PAGE>
                                                                   EXHIBIT 10.20

                         OMRIX BIOPHARMACEUTICALS, INC.

                           2004 EQUITY INCENTIVE PLAN

      This 2004 Equity Incentive Plan (the "Plan") is intended to encourage
ownership of Common Stock, $0.01 par value (the "Stock"), of Omrix
Biopharmaceuticals, Inc., a Delaware corporation (the "Company") by directors,
officers, employees and consultants of the Company and its Affiliates (as
defined below) through the grant of Awards in order to attract, motivate and
retain outstanding individuals for such positions, to align their interests with
those of the Company's shareholders, and to provide them with appropriate
compensation and additional incentives to promote the success of the Company.

      1. Certain Definitions.

      "Affiliate" means any business entity in which the Company owns directly
or indirectly 50% or more of the total voting power or has a significant
financial interest as determined by the Board.

      "Award" means any Option, Stock Award or Stock Equivalent granted under
Section 4, 5 or 6 of the Plan.

      "Board" means the Board of Directors of the Company.

      "Code" means the Internal Revenue Code of 1986, as amended from time to
time, or any successor law.

      "Committee" means one or more committees each comprised of not less than
two members of the Board appointed by the Board to administer the Plan or a
specified portion thereof or, in the absence of such appointment, the
Compensation Committee of the Board.

      "Fair Market Value" means, with respect to the Stock or any other
property, the fair market value of such property as determined by the Board in
good faith.

      "Option" means any Nonstatutory Stock Option or Incentive Stock Option
granted under Section 3 of the Plan.

      "Participant" means an individual selected by the Board or the Committee
to receive an Award under the Plan.

      2. Administration of the Plan. The administration of the Plan shall be
under the general supervision of the Board, which shall, within the limits of
the Plan, determine the Participants to whom and the times at which Awards shall
be granted. The Board may establish such rules as it deems necessary for the
proper administration of the Plan, make such determinations and interpretations
with respect to the Plan and Awards granted under it as may be necessary or
desirable and include such further provisions or conditions with respect to
which Awards may be granted under the Plan as it deems advisable. To the extent
permitted by law, the Board may delegate its authority under the Plan to a
Committee of the Board. References to the Board herein shall include a Committee
as applicable.

<PAGE>

      3. Shares Subject to the Plan.

            (a) Number and Type of Shares. The aggregate number of shares of
Stock of the Company that may be issued pursuant to Awards granted under the
Plan is 3,275,636 shares of Common Stock. Shares issued hereunder may consist in
whole or in part of authorized but unissued shares or treasury shares.

            (b) Adjustments; Assumption of Options. In the event (i) of any
stock dividend, split-up or combination of shares effected proportionately with
respect to all outstanding shares of Stock, or (ii) the Board determines that
any other recapitalization or any extraordinary cash dividend, reorganization,
merger, consolidation, spin-off, exchange of shares or other similar capital
change affects the Stock such that adjustment is required in order to preserve
the benefits or potential benefits of the Plan or any Award granted under the
Plan, the Board (whose determination shall be conclusive) shall appropriately
adjust any or all of (i) the number and kind of shares or securities of the
Company that may be issued under the Plan, (ii) the number and kind of shares
subject to outstanding Awards, and (iii) the exercise price or repurchase price
with respect to any of the foregoing, so that the proportionate number of shares
or other securities as to which Awards may be granted and the proportionate
interest of holders of outstanding Awards shall be maintained as before the
occurrence of such event. In the event of any reorganization, merger,
consolidation, spin-off or exchange of shares, the Board in its discretion may
cause any Award to be assumed, or new rights substituted therefor, by another
entity party to the transaction.

            (c) Restoration of Shares. Shares subject to an Award that expires,
is terminated unexercised, is forfeited for any reason, or is settled in a
manner that results in fewer shares outstanding than were initially awarded,
shares surrendered in payment of the option price or any tax obligation with
respect to an Award, and shares of Restricted Stock that are repurchased by, or
forfeited to, the Company shall again be available for granting Awards under the
Plan to the extent of such expiration, termination, forfeiture, repurchase or
decrease subject, however, in the case of Incentive Stock Options, to any
requirements under the Code.

      4. Options.

            (a) Types of Options. Options shall be granted under the Plan either
as incentive stock options ("Incentive Stock Options"), as defined in Section
422 of the Code, or as Options that do not meet the requirements of Section 422
("Nonstatutory Stock Options"). Options may be granted from time to time by the
Board to all employees of the Company or of any parent or subsidiary company of
the Company (as defined in Sections 424(e) and (f), respectively, of the Code),
and Nonstatutory Stock Options may also be granted to all non-employee directors
and consultants of the Company or any such other company.

            (b) Date of Grant. The date of grant for each Option shall be the
date on which it is approved by the Board, or such later date as the Board may
specify. No Incentive Stock Options shall be granted hereunder after ten years
from the last date on which the Plan was approved for purposes of Section 422 of
the Code.

                                       2
<PAGE>

            (c) Option Price. The price at which shares may from time to time be
purchased (the "option price") under each Incentive Stock Option shall be
determined by the Board, provided that such price shall not be less than the
Fair Market Value of the Stock on the date of grant; and provided further that
no Option granted to any individual who is ineligible to be granted an Incentive
Stock Option because his ownership of stock of the Company or its parent or
subsidiary companies exceeds the limitations set forth in Section 422(b)(6) of
the Code shall be an Incentive Stock Option unless the option price thereof is
at least 110% of the Fair Market Value of the Stock on the date of grant. The
option price of each Nonstatutory Stock Option shall be determined by the Board.

            (d) Payment. No shares of Stock shall be delivered upon exercise of
an Option until the Company receives full payment for the exercise price
therefore. Payment of the exercise price may be made in cash or, to the extent
permitted by the Board at or after the grant of the Option, pursuant to any of
the following methods: (i) by delivery of a promissory note, (ii) by actual
delivery or attestation of ownership of shares of Common Stock owned by the
Participant, or (iii) for such other lawful consideration as the Board may
determine.

            (e) Term of Option; Exercisability. The Board shall determine the
term of all Options, the time or times that Options become exercisable and
whether they become exercisable in installments; provided, however, that the
term of each Incentive Stock Option shall not exceed a period of ten years from
the date of its grant, and provided further that no Option granted to any
individual who is ineligible to be granted such Option because his ownership of
stock of the Company or its parent or subsidiary companies exceeds the
limitations set forth in Section 422(b)(6) of the Code shall be an Incentive
Stock Option unless the term thereof does not exceed a period of five years from
the date of its grant.

            (f) Effect of Disability, Death or Termination of Employment. The
Board shall determine the effect on an Option of the disability, death,
retirement or other termination of employment of a Participant and the extent to
which, and the period during which, the Participant's estate, legal
representative, guardian, or beneficiary on death may exercise rights
thereunder. Any beneficiary on death shall be designated by the Participant, in
the manner determined by the Board, to exercise rights of the Participant in the
case of the Participant's death.

            (g) Form of Options. Options granted hereunder shall be evidenced by
an instrument delivered to the Participant specifying the terms and conditions
thereof and containing such other terms and conditions not inconsistent with the
provisions of the Plan as the Board considers necessary or advisable to achieve
the purposes of the Plan or comply with applicable tax and regulatory laws and
accounting principles. The form of Options may vary among Participants; provided
that, in the absence of a specific determination in any particular case, the
forms of Incentive and Nonstatutory Stock Option shall be as set forth in
Exhibits A and B hereto, respectively.

            (h) Amendment or Termination of Options. The Board may amend,
modify, or terminate any outstanding Option, including substituting therefor
another Option of the same or a different type, changing the date of exercise or
realization and converting an Incentive Stock

                                       3
<PAGE>

Option to a Nonstatutory Stock Option. Any such action shall require the
Participant's consent unless:

                  (i) in the case of a termination of, or a reduction in the
number of shares issuable under, an Option, any time period relating to the
exercise of such Option or the eliminated portion, as the case may be, is waived
or accelerated before such termination or reduction (or in such case the Board
may provide for the Participant to receive cash or other property equal to the
net value that would have been received upon exercise of the terminated Option
or the eliminated portion, as the case may be); or

                  (ii) in any other case, the Board determines that the action,
taking into account any related action, would not materially and adversely
affect the Participant.

            (i) No Rights as a Shareholder. No Participant or any person
claiming through a Participant shall have any rights as a shareholder with
respect to any shares of Stock to be distributed under the Plan until he or she
becomes the holder thereof.

      5. Stock Awards.

            (a) Terms. The Board may issue shares of Stock ("Stock Awards") to
employees, non-employee directors and consultants upon such terms and conditions
as the Board determines, including without limitation, Stock free of forfeiture
provisions ("Unrestricted Stock"), Stock subject to forfeiture or to the
Company's right to repurchase such shares ("Restricted Stock"), bonus stock or
performance shares. Stock Awards may be issued without cash consideration or for
such consideration as may be determined by the Board. The Board shall determine
the duration of the period of time (the "Restricted Period") during which, the
price (if any) at which, and the other conditions under which, the shares may be
forfeited or repurchased by the Company and other terms and conditions of such
grants.

            (b) Restrictions. Shares of Restricted Stock may not be sold,
assigned, transferred, pledged or otherwise encumbered, except as permitted by
the Board, during the Restricted Period. Any certificates issued in respect of
shares of Restricted Stock shall be registered in the name of the holder, shall
contain such legend as the Board may require with respect to the restrictions on
transfer and, if required by the Board, shall be deposited by the holder,
together with a stock power endorsed in blank, with the Company. At the
expiration of the Restricted Period with respect to any of such shares, the
Company shall deliver a certificate with respect to such shares, without a
legend referring to the Plan's restrictions on transfer, to the Participant or,
if the Participant has died, to the Participant's designated beneficiary or
legal representative.

            (c) Stock Purchase Agreement. Each recipient of a Stock Award shall
enter into a Stock Purchase Agreement with the Company that shall specify the
terms and conditions of such Stock Award and shall contain such other terms and
conditions not inconsistent with the provisions of this Plan as the Board
considers necessary or advisable to achieve the purposes of the Plan or comply
with applicable tax and regulatory laws and accounting principles. The form of
such Stock Purchase Agreement may vary among Participants. The Stock Purchase
Agreement may be amended by the Board in any respect, provided that the consent
of the

                                       4
<PAGE>

Participant shall be required for any amendment, other than an amendment made in
order to conform the Stock Purchase Agreement or the Plan to restrictions
imposed by securities or tax laws or regulations, that would materially and
adversely affect the Participant.

      6. Stock Equivalents. The Board may grant rights to receive payment from
the Company based in whole or in part on the value of the Stock ("Stock
Equivalents") upon such terms and conditions as the Board determines. Stock
Equivalents may include without limitation phantom stock, performance units,
dividend equivalents and stock appreciation rights ("SARs"). SARs granted in
tandem with an Option will terminate to the extent that the related Option is
exercised, and the related Option will terminate to the extent that the tandem
SARs are exercised. A SAR will have an exercise price determined by the Board.
In the case of a SAR granted in tandem with an Option, such exercise price will
be not less than the exercise price of the related Option. The Board will
determine at the time of grant or thereafter whether Stock Equivalents are to be
settled in cash, Common Stock or other securities of the Company, other Awards
or other property.

      7. Transferability. An Option or Stock Equivalent (i) shall not be
transferable other than as designated by the Participant by will or by the laws
of descent and distribution, and (ii) may be exercised during the Participant's
life only by the Participant or the Participant's guardian or legal
representative. The Board may waive this restriction in any particular case,
provided that Incentive Stock Options may be transferable only to the extent
permitted by the Code.

      8. No Right to Employment. No person shall have any claim or right to be
granted an Award, and any grant of an Award shall not be construed as giving the
Participant the right to continued employment. The Company expressly reserves
the right at any time to dismiss a Participant free from any liability or claim
under the Plan except as specifically provided in the applicable Award.

      9. Documentation; Shareholder Agreement; Other Conditions. Each Award
under the Plan shall be evidenced by a writing delivered to the Participant
specifying the terms and conditions thereof and containing such other terms and
conditions not inconsistent with the Plan as the Board considers necessary and
advisable. The Board may at the time of grant of an Award or at any time
thereafter, require as a condition for exercise of an Option or receipt of a
Stock Award or Stock Equivalent that the Participant execute a Shareholder
Agreement containing such provisions relating to voting, restrictions on
transferability, first refusal rights, co-sale rights, etc., and otherwise as
the Board may deem necessary or desirable and may at any time impose such
additional conditions with respect to the issuance and/or delivery of stock
under the Plan as it considers necessary or advisable to comply with the
requirements of securities, tax or other laws or regulations, including without
limitation restricting the transfer of such shares and requiring appropriate
representations and agreements from the Participant, and the Company shall be
entitled to postpone such issuance or delivery until such conditions have been
met.

      10. Withholding. The Participant shall pay to the Company, or make
provision satisfactory to the Board for payment of, any taxes required by law to
be withheld in respect of any Award no later than the date of the event creating
the tax liability. In the Board's discretion, such tax obligations may be paid
in whole or in part in shares of Stock, including shares retained

                                       5
<PAGE>

from the exercise of the Option or from the grant of a Stock Award creating the
tax obligation, valued at the Fair Market Value of the Stock on the date of
delivery to the Company. The Company and any of its affiliates may, to the
extent permitted by law, deduct any such tax obligations from any payment of any
kind otherwise due to the Participant.

      11. Amendment or Termination. The Board may amend or terminate the Plan at
any time, subject to such approval of the shareholders as the Board shall deem
necessary or advisable.

      12. Shareholder Approval. The Plan shall be presented for approval by the
shareholders of the Company within twelve (12) months from the date the Plan was
adopted by the Board. In the event such approval is not obtained, all Incentive
Stock Options granted under the Plan shall be deemed to be Nonstatutory Stock
Options and no further Incentive Stock Options may be granted, but the
provisions of the Plan regarding other Awards shall remain in effect.

      13. Governing Law. The provisions of the Plan shall be governed by and
interpreted in accordance with the laws of the State of Delaware.

                                *****************

      Adopted by the Board of Directors on December 17, 2004 and approved by the
shareholders as of January 13, 2005.

                                       6
<PAGE>

                   EXHIBIT A - FORM OF INCENTIVE STOCK OPTION

2004 ISO-____                                                     _______ Shares

                         OMRIX BIOPHARMACEUTICALS, INC.
                           2004 Equity Incentive Plan
                       Incentive Stock Option Certificate

      Omrix Biopharmaceuticals, Inc., a Delaware corporation (the "Company"),
hereby grants to the person named below an option to purchase shares of Common
Stock, $.01 par value, of the Company (the "Option") under and subject to the
Company's 2004 Equity Incentive Plan (the "Plan") exercisable on the following
terms and conditions and those set forth on the reverse side of this
certificate:

      Name of Optionee:                              ___________________________

      Address:                                       ___________________________
                                                     ___________________________
                                                     ___________________________
                                                     ___________________________

      Social Security No.:                           ___________________________

      Number of Shares:                              ___________________________

      Option Price:                                  ___________________________

      Date of Grant:                                 ___________________________

      Exercisability Schedule:

      Expiration Date:                               ___________________________

      This Option is intended to be treated as an Incentive Stock Option under
section 422 of the Internal Revenue Code of 1986, as amended (the "Code").

      By acceptance of this Option, the Optionee agrees to the terms and
conditions set forth in this Agreement and in the Plan.

OPTIONEE                             Omrix Biopharmaceuticals, Inc.

_______________________________      By:_____________________________________
[Name]                                  [Name]
                                        Title:

                                       7
<PAGE>

                   Incentive Stock Option Terms And Conditions

1. Plan Incorporated by Reference. This Option is issued pursuant to the terms
of the Plan and may be amended as provided in the Plan. Capitalized terms used
and not otherwise defined in this certificate have the meanings given to them in
the Plan. This certificate does not set forth all of the terms and conditions of
the Plan, which are incorporated herein by reference. The Board of Directors or
a Committee thereof (the "Administrator") administers the Plan and its
determinations regarding the interpretation and operation of the Plan are final
and binding. Copies of the Plan may be obtained upon request without charge from
the Company.

2. Option Price. The price to be paid for each share of Stock issued upon
exercise of the whole or any part of this Option is the Option Price set forth
on the face of this certificate.

3. Exercisability Schedule. This Option may be exercised at any time and from
time to time for the number of shares and in accordance with the exercisability
schedule set forth on the face of this certificate, but only for the purchase of
whole shares. This Option may not be exercised as to any shares after the
Expiration Date.

4. Method of Exercise. To exercise this Option, the Optionee shall deliver (a)
written notice of exercise in the form attached as Exhibit A hereto, to the
Company specifying the number of shares with respect to which the Option is
being exercised, (b) payment of the Option Price for such shares in cash, by
certified check or money order to the order of the Company or in such other
form, including shares of Stock of the Company valued at their Fair Market Value
on the date of delivery, as the Administrator may approve in its discretion, and
(c) a signed Instrument of Accession to the Stockholders' Agreement among the
Company and certain stockholders (the "Stockholders' Agreement") in the form
attached as Exhibit B hereto, as such Stockholders' Agreement may be amended
from time to time. In connection with any purchase of shares pursuant to an
exercise of this Option, the Company may also require the Optionee to execute a
Stock Purchase Agreement in a form reasonable acceptable to the Company.
Promptly following such receipt of notice and other required documentation, the
Company will deliver to the Optionee a certificate representing the number of
shares with respect to which the Option is being exercised.

5. Rights as a Shareholder or Employee. The Optionee shall not earn the right to
exercise or obtain the value of any portion of this Option except as provided in
the exercisability schedule and until such time as all the conditions set forth
herein and in the Plan that are required to be met in order to exercise this
Option have been fully satisfied. No portion of this Option shall be deemed
compensation for past services before it has become exercisable in accordance
with the exercisability schedule. The Optionee shall not have any rights in
respect of shares as to which the Option shall not have been exercised and
payment made as provided above. The Optionee shall not have any rights to
continued employment by the Company or its affiliates by virtue of the grant of
this Option.

6. Recapitalization, Mergers, Etc. As provided in and subject to the Plan, in
the event of a merger, recapitalization or other corporate transaction involving
the Company, the Administrator may in its discretion take certain actions
affecting the Option and the Optionee's rights hereunder, including without
limitation adjusting the number and kind of securities subject to the Option and
the exercise price hereunder, providing for another entity to assume the Option,
making provision for a cash payment, and terminating the Option.

7. Option Not Transferable. This Option is not transferable by the Optionee
otherwise than by will or the laws of descent and distribution, and is
exercisable, during the Optionee's lifetime, only by the Optionee.

8. Exercise of Option After Termination of Employment. If the Optionee's
employment with (a) the Company, (b) an Affiliate, or (c) a corporation (or
parent or subsidiary corporation of such corporation) issuing or assuming a
stock option in a transaction to which section 424(a) of the Code applies, is
terminated for any reason other than by disability (within the meaning of
section 22(e)(3) of the Code) or death, the Optionee may exercise only the
rights that were available to the Optionee at the time of such termination and
only within three months from the date of termination. If the Optionee's
employment is terminated as a result of disability, such rights may be exercised
only within twelve months from the date of termination. Upon the death of the
Optionee, his or her designated beneficiary or legal representative shall have
the right, at any time within twelve months after the date of death, to exercise
in whole or in part any rights that were available to the Optionee at the time
of death. Notwithstanding the foregoing, no rights under this Option may be
exercised after the Expiration Date.

9. Compliance with Securities Laws. It shall be a condition to the Optionee's
right to purchase shares of Stock hereunder that the Company may, in its
discretion, require (a) that the shares of Stock reserved for issue upon the
exercise of this Option shall have been duly listed, upon official notice of
issuance, upon any national securities exchange or automated quotation system on
which the Company's Stock may then be listed or quoted, (b) that either (i) a
registration statement under the Securities Act of 1933 with respect to the
shares shall be in effect, or (ii) in the opinion of counsel for the Company,
the proposed purchase shall be exempt from registration under that Act and the
Optionee shall have made such undertakings and agreements with the Company as
the Company may reasonably require, and (c) that such other steps, if any, as
counsel for the Company shall consider necessary to comply with any law
applicable to the issue of such shares by the Company shall have been taken by
the Company or the Optionee, or both. The certificates representing the shares
purchased under this Option may contain such legends as counsel for the Company
shall consider necessary to comply with any applicable law.

10. Optionee's Tax Treatment. This Option is intended to be treated as an
incentive stock option under section 422 of the Code. However, incentive stock
option treatment requires compliance with a variety of factors, and the Company
can give no assurance that the Option will, in fact, be treated as an incentive
stock option.

11. Notice of Sale of Shares Required. The Optionee agrees to notify the Company
in writing within 30 days of the disposition of any shares purchased upon
exercise of this Option if such disposition occurs within two years of the date
of the grant of this Option or within one year after such purchase.

                                                              Approved [  ] 2004

<PAGE>

                 EXHIBIT B -- FORM OF NONSTATUTORY STOCK OPTION

2004 NSO-___                                                       ______ Shares

                         OMRIX BIOPHARMACEUTICALS, INC.
                           2004 Equity Incentive Plan
                      Nonstatutory Stock Option Certificate

      Omrix Biopharmaceuticals, Inc., a Delaware corporation (the "Company"),
hereby grants to the person named below an option to purchase shares of Common
Stock, $.01 par value, of the Company (the "Option") under and subject to the
Company's 2004 Equity Incentive Plan (the "Plan") exercisable on the following
terms and conditions and those set forth on the reverse side of this
certificate:

      Name of Optionee:                              ___________________________

      Address:                                       ___________________________
                                                     ___________________________
                                                     ___________________________
                                                     ___________________________

      Social Security No.:                           ___________________________

      Number of Shares:                              ___________________________

      Option Price:                                  ___________________________

      Date of Grant:                                 ___________________________

      Exercisability Schedule:

      Expiration Date:                               ___________________________

      This Option is not intended to be treated as an Incentive Stock Option
under section 422 of the Internal Revenue Code of 1986, as amended (the "Code").

      By acceptance of this Option, the Optionee agrees to the terms and
conditions set forth in this Agreement and in the Plan.

OPTIONEE                                   Omrix Biopharmaceuticals, Inc.

______________________________             By:__________________________________
[name]                                        [name]
                                              Title:

                                       9
<PAGE>

                 Nonstatutory Stock Option Terms And Conditions

1. Plan Incorporated by Reference. This Option is issued pursuant to the terms
of the Plan and may be amended as provided in the Plan. Capitalized terms used
and not otherwise defined in this certificate have the meanings given to them in
the Plan. This certificate does not set forth all of the terms and conditions of
the Plan, which are incorporated herein by reference. The Board of Directors or
a Committee thereof (the "Administrator") administers the Plan and its
determinations regarding the interpretation and operation of the Plan are final
and binding. Copies of the Plan may be obtained upon request without charge from
the Company.

2. Option Price. The price to be paid for each share of Stock issued upon
exercise of the whole or any part of this Option is the Option Price set forth
on the face of this certificate.

3. Exercisability Schedule. This Option may be exercised at any time and from
time to time for the number of shares and in accordance with the exercisability
schedule set forth on the face of this certificate, but only for the purchase of
whole shares. This Option may not be exercised as to any shares after the
Expiration Date.

4. Method of Exercise. To exercise this Option, the Optionee shall deliver (a)
written notice of exercise in the form attached as Exhibit A hereto, to the
Company specifying the number of shares with respect to which the Option is
being exercised, (b) payment of the Option Price for such shares in cash, by
certified check or money order to the order of the Company or in such other
form, including shares of Stock of the Company valued at their Fair Market Value
on the date of delivery, as the Administrator may approve in its discretion, and
(c) a signed Instrument of Accession to the Stockholders' Agreement among the
Company and certain stockholders (the "Stockholders' Agreement") in the form
attached as Exhibit B hereto, as such Stockholders' Agreement may be amended
from time to time. In connection with any purchase of shares pursuant to an
exercise of this Option, the Company may also require the Optionee to execute a
Stock Purchase Agreement in a form reasonable acceptable to the Company.
Promptly following such receipt of notice and other required documentation, the
Company will deliver to the Optionee a certificate representing the number of
shares with respect to which the Option is being exercised.

5. Rights as a Shareholder or Employee. The Optionee shall not earn the right to
exercise or obtain the value of any portion of this Option except as provided in
the exercisability schedule and until such time as all the conditions set forth
herein and in the Plan that are required to be met in order to exercise this
Option have been fully satisfied. No portion of this Option shall be deemed
compensation for past services before it has become exercisable in accordance
with the exercisability schedule. The Optionee shall not have any rights in
respect of shares as to which the Option shall not have been exercised and
payment made as provided above. The Optionee shall not have any rights to
continued employment or other service by the Company or its affiliates by virtue
of the grant of this Option.

6. Recapitalization, Mergers, Etc. As provided in and subject to the Plan, in
the event of a merger, recapitalization or other corporate transaction involving
the Company, the Administrator may in its discretion take certain actions
affecting the Option and the Optionee's rights hereunder, including without
limitation adjusting the number and kind of securities subject to the Option and
the exercise price hereunder, providing for another entity to assume the Option,
making provision for a cash payment, and terminating the Option.

7. Option Not Transferable. Unless otherwise determined by the Administrator,
this Option is not transferable by the Optionee otherwise than, if an
individual, by will or the laws of descent and distribution, and is exercisable,
during the Optionee's lifetime, only by the Optionee.

[FOR EMPLOYEES] 8. Exercise of Option After Termination of Employment. If the
Optionee's employment with (a) the Company, (b) an Affiliate, or (c) a
corporation (or parent or subsidiary corporation of such corporation) issuing or
assuming a stock option in a transaction to which section 424(a) of the Code
applies, is terminated for any reason other than by disability (within the
meaning of section 22(e)(3) of the Code) or death, the Optionee may exercise
only the rights that were available to the Optionee at the time of such
termination and only within three months from the date of termination. If the
Optionee's employment is terminated as a result of disability, such rights may
be exercised only within twelve months from the date of termination. Upon the
death of the Optionee, his or her designated beneficiary or legal representative
shall have the right, at any time within twelve months after the date of death,
to exercise in whole or in part any rights that were available to the Optionee
at the time of death. Notwithstanding the foregoing, no rights under this Option
may be exercised after the Expiration Date.

[FOR CONSULTANTS/DIRECTORS](1) 8. Exercise of Option After Termination of
Consulting Relationship/Services Engagement. If the Optionee's consulting
relationship or other services engagement with the Company or any of its
affiliates is terminated for any reason, the Optionee or the Optionee's legal
representative may exercise only the rights that were available to the Optionee
at the time of such termination and only within three months from the date of
termination. Notwithstanding the foregoing, no rights under this Option may be
exercised after the Expiration Date.

9. Compliance with Securities Laws. It shall be a condition to the Optionee's
right to purchase shares of Stock hereunder that the Company may, in its
discretion, require (a) that the shares of Stock reserved for issue upon the
exercise of this Option shall have been duly listed, upon official notice of
issuance, upon any national securities exchange or automated quotation system on
which the Company's Stock may then be listed or quoted, (b) that either (i) a
registration statement under the Securities Act of 1933 with respect to the
shares shall be in effect, or (ii) in the opinion of counsel for the Company,
the proposed purchase shall be exempt from registration under that Act and the
Optionee shall have made such undertakings and agreements with the Company as
the Company may reasonably require, and (c) that such other steps, if any, as
counsel for the Company shall consider necessary to comply with any law
applicable to the issue of such shares by the Company shall have been taken by
the Company or the Optionee, or both. The certificates representing the shares
purchased under this Option may contain such legends as counsel for the Company
shall consider necessary to comply with any applicable law.

10. Payment of Taxes. The Optionee shall pay to the Company, or make provision
satisfactory to the Company for payment of, any taxes required by law to be
withheld with respect to the exercise of this Option. The Administrator may, in
its discretion, require any other Federal or state taxes imposed on the sale of
the shares to be paid by the Optionee. In the Administrator's discretion, such
tax obligations may be paid in whole or in part in shares of Stock, including
shares retained from the exercise of this Option, valued at their Fair Market
Value on the date of delivery. The Company and its affiliates may, to the extent
permitted by law, deduct any such tax obligations from any payment of any kind
otherwise due to the Optionee.

----------
(1)   In the case of a consultant, the termination provision will need to
      be consistent with the respective consulting agreement.

<PAGE>

                           EXHIBIT A FORM OF EXERCISE

                                                              Exercise #________

                         OMRIX BIOPHARMACEUTICALS, INC.
                           2004 EQUITY INCENTIVE PLAN
                                FORM OF EXERCISE

      The undersigned employee of or consultant to OMRIX BIOPHARMACEUTICALS,
INC. (the "Company"), pursuant to its 2004 Equity Incentive Plan (the "Plan")
and pursuant to option certificate number ______________ dated ________________,
hereby agrees to purchase from the Company _____________ shares of Common Stock,
$.01 par value, at an exercise price of $___________ per share for a total
purchase price of $_____________.

      Name of Optionholder:                           __________________________

      Address:                                        __________________________

                                                      __________________________

                                                      __________________________

      Social Security No.                             __________________________

The above Optionholder has delivered the following consideration to the Company
in exchange for the shares of Common Stock listed above:

      (1) $__________ in cash or by check.

      (2) The above Optionholder has executed and delivered to the Company two
Instruments of Accession to the Stockholders' Agreement with respect to the
shares of Common Stock listed above.

      IN WITNESS WHEREOF, the undersigned Optionholder has executed this Form of
Exercise this ________ day of ___________________, 20____.

__________________________________             _________________________________
Signature of Optionholder                      Date of Exercise

                                       11
<PAGE>

                                    EXHIBIT B

                         OMRIX BIOPHARMACEUTICALS, INC.
                       STOCKHOLDER INSTRUMENT OF ACCESSION

      The undersigned, ______________________, as a condition precedent to
becoming the owner or holder of record of __________________ (_________) shares
of Common Stock, par value $0.01 per share, of Omrix Biopharmaceuticals, Inc., a
Delaware corporation (the "Company"), hereby agrees to become a Stockholder
under that certain Stockholders' Agreement dated as of December ___, 2004 by and
among the Company and the Common Stockholders named therein, as the same as may
be amended from time to time, including by accession of additional parties. This
Instrument of Accession shall take effect and shall become an integral part of,
and the undersigned shall become a party to and bound by, said Stockholders'
Agreement immediately upon execution and delivery to the Company of this
Instrument.

      IN WITNESS WHEREOF, this INSTRUMENT OF ACCESSION has been duly executed by
or on behalf of the undersigned as of the date below written.

                                           [NAME]

                                           By:__________________________________
                                           Name:________________________________
                                           Title:_______________________________

                                           Record Address:______________________
                                           _____________________________________
                                           _____________________________________

                                           Telephone No.:_______________________
                                           Facsimile No.:_______________________

                                           E-mail Address:______________________

                                           ACCEPTED:

                                           OMRIX BIOPHARMACEUTICALS, INC.

                                           By:__________________________________
                                           Name:________________________________
                                           Title:_______________________________

                                           Date:________________________________

                                       12

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00096-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00096-of-00352.parquet"}]]